SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018818
Filing Date
2019-05-13
Accepted
2019-05-13 16:01:17
Documents
50
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 MARCH 31, 2019 FORM 10-Q ogen-10q_20190331.htm 10-Q 818580
2 EX-31.1 ogen-ex311_7.htm EX-31.1 9437
3 EX-31.2 ogen-ex312_8.htm EX-31.2 9228
4 EX-32.1 ogen-ex321_9.htm EX-32.1 5783
5 EX-32.2 ogen-ex322_6.htm EX-32.2 5765
  Complete submission text file 0001564590-19-018818.txt   3244156

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ogen-20190331.xml EX-101.INS 537025
7 XBRL TAXONOMY EXTENSION SCHEMA ogen-20190331.xsd EX-101.SCH 39054
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogen-20190331_cal.xml EX-101.CAL 24921
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogen-20190331_def.xml EX-101.DEF 131475
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogen-20190331_lab.xml EX-101.LAB 253950
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogen-20190331_pre.xml EX-101.PRE 203961
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 19818330
SIC: 2834 Pharmaceutical Preparations